Hanmi received KT mark on Amodipin.
Published: 2005-09-15 06:58:00
Updated: 2005-09-15 06:58:00
Hanmi recently received the domestic technology award of "Excellent Korean Technology" for Amodipin, an anti-hypertension drug during the Q3 2005 Technology Recognition occasion of the Korea Industrial Technology Association (KITA) at Yangjae dong on Sept. 7.
The KT certification is granted ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
